Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: A randomized controlled trial

Shock

Volumn 35, Issue 1, 2011, Pages 9-16

  Diepenhorst, Gwendolyn M P ^a,b   Van Ruler, Oddeke ^a   Besselink, Marc G H ^c   Van Santvoort, Hjalmar C ^c   Wijnandts, Paul R ^a   Renooij, Willem ^c   Gouma, Dirk J ^a   Gooszen, Hein G ^c   Boermeester, Marja A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bacterial translocation; intestinal barrier function; major abdominal surgery; probiotics; selective decontamination of the digestive tract

Indexed keywords

AMPHOTERICIN B; BACTERIAL DNA; CEFOTAXIME; CEFUROXIME; COLISTIN; FATTY ACID BINDING PROTEIN 2; MACROGOL; METRONIDAZOLE; PROBIOTIC AGENT; TOBRAMYCIN;

ABDOMINAL SURGERY; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HUMAN; INTESTINE MUCOSA PERMEABILITY; MALE; MESENTERY LYMPH NODE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; PYLORUS PRESERVING PANCREATICODUODENECTOMY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; BACTERIAL TRANSLOCATION; FATTY ACID-BINDING PROTEINS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LYMPH NODES; MALE; MESENTERY; MIDDLE AGED; OROPHARYNX; PANCREAS; PANCREATICODUODENECTOMY; POLYETHYLENE GLYCOLS; POLYMYXINS; PROBIOTICS; YOUNG ADULT;

EID: 78650767957     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ed8f17     Document Type: Article

References (35)

1. Nieuwenhuijzen GA, Deitch EA, Goris RJ: Infection, the gut and the development of the multiple organ dysfunction S-ndrome. Eur J Surg 162(4):259-273, 1996.
2. van Santvoort HC, Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG: Probiotics in surgery. Surgery 143(1):1-7, 2008.
3. Leaphart CL, Tepas JJ, III: The gut is a motor of organ S-stem dysfunction. Surgery 141(5):563-569, 2007.
4. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ: Bacterial trans-location studied in 927 patients over 13 years. Br J Surg 93(1):87-93, 2006.
5. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC: Microbiology of bacterial translocation in humans. Gut 42(1):29-35, 1998.
6. Tsujimoto H, Ono S, Mochizuki H: Role of translocation of pathogen-associated molecular patterns in sepsis. Dig Surg 26(2):100-109, 2009.
7. Anderson AD, McNaught CE, Jain PK, MacFie J: Randomised clinical trial of S-nbiotic therapy in elective surgical patients. Gut 53(2):241-245, 2004. (Pubitemid 38125512)
8. Schoeffel U, Pelz K, Haring RU, Amberg R, Schandl R, Urbaschek R, von Specht BU, Farthmann EH: Inflammatory consequences of the trans-location of bacteria and endotoxin to mesenteric lymph nodes. Am J Surg 180(1):65-72, 2000.
9. Gebbers JO, Laissue JA: Bacterial translocation in the normal human appendix parallels the development of the local immune S-stem. Ann N Y Acad Sci 1029:337-343, 2004.
10. Gatt M, Reddy BS, MacFie J: Review article: bacterial translocation in the critically illVevidence and methods of prevention. Aliment Pharmacol Ther 25(7):741-757, 2007.
11. De Jonge E., Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 27 362(9389):1011-1016, 2003.
12. De la Cal MA, Cerda E, Garcia-Hierro P, van Saene HK, Gomez-Santos D, Negro E, Lorente JA: Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Ann Surg 241(3):424-430, 2005.
13. De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, et al.: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20-31, 2009.
14. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E: Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database S-st Rev (4):CD000022, 2009.
15. Reddy BS, MacFie J, Gatt M, Larsen CN, Jensen SS, Leser TD: Randomized clinical trial of effect of S-nbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 94(5):546-554, 2007.
16. Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A: Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. S-stematic review of randomized, controlled trials. J Hosp Infect 65(3):187-203, 2007.
17. Seehofer D, Rayes N, Schiller R, Stockmann M, Muller AR, Schirmeier A, Schaeper F, Tullius SG, Bengmark S, Neuhaus P: Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats. J Surg Res 117(2):262-271, 2004.
18. van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR, Smidt H, Visser MR, Rijkers GT, Gooszen HG, et al.: Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 141(4):470-480, 2007.
19. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E: Benefits of a S-nbiotic formula (S-nbiotic 2000 Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 30(10):1848-1855, 2006.
20. McNaught CE, Woodcock NP, Anderson AD, MacFie J: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 24(2):211-219, 2005.
21. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371(9613):651-659, 2008.
22. Whelan K, Myers CE: Safety of probiotics in patients receiving nutritional support: a S-stematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 91(3):687-703, 2010.
23. White JS, Hoper M, Parks RW, Clements WD, Diamond T: Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res 132(1):80-84, 2006.
24. Timmerman HM, Niers LE, Ridwan BU, Koning CJ, Mulder L, Akkermans LM, Rombouts FM, Rijkers GT: Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr 26(4):450-459, 2007.
25. Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, Timmerman HM, Ahmed AU, Cirkel GA, Bollen TL, et al.: Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg 250(5):712-718, 2009.
26. Pelsers MM, Hermens WT, Glatz JF: Fatty acidYbinding proteins as plasma markers of tissue injury. Clin Chim Acta 352(1-2):15-35, 2005.
27. Lane DJ: 16S/23S rRNA Sequencing. Nucleic Acid Techniques in Bacterial S-stematics. New York: John Wiley & Sons, Ltd; 1991:115-175.
28. Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF, McElgunn CJ, Schouten JP: Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 31(23):e153, 2003.
29. Moore FA, Moore EE, Poggetti RS, Read RA: Postinjury shock and early bacteremia. A lethal combination. Arch Surg 127(8):893-897, 1992.
30. Fink MP, Delude RL: Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21(2):177-196, 2005.
31. Reddy BS, Gatt M, Sowdi R, MacFie J: Surgical manipulation of the large intestine increases bacterial translocation in patients undergoing elective colo-rectal surgery. Colorectal Dis 8(7):596-600, 2006.
32. Hietbrink F, Besselink MG, Renooij W, de Smet MB, Draisma A, van der Hoeven H, Pickkers P: S-stemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32(4):374-378, 2009.
33. Watson AJ, Chu S, Sieck L, Gerasimenko O, Bullen T, Campbell F, McKenna M, Rose T, Montrose MH: Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 129(3):902-912, 2005.
34. Oliver JD: Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev 34(4): 415-425, 2009.
35. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P: Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123-127, 2002.